VANGUARD GROUP INC 13D and 13G filings for Kiniksa Pharmaceuticals International, plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 10:17 am Sale | 2026-03-13 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | VANGUARD GROUP INC | 0 0.000% | -3,063,135 (Position Closed) | Filing |
| 2025-10-31 11:04 am Purchase | 2025-09-30 | 13G | KINIKSA PHARMACEUTICALS INTL P KNSA | VANGUARD GROUP INC | 3,063,135 7.040% | 97,836 (+3.30%) | Filing |